- Investing Ideas
- /
- French Pharmaceuticals & Biotech Financially Fit Penny Stocks
French Pharmaceuticals & Biotech Financially Fit Penny Stocks
Results
5
0 new
A Penny Stocks screener, typically smaller or younger companies trading at a price below 5, with a focus on solid financial health that should present companies with a lower risk profile than other early-stage businesses
5 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
AELIS | €2.48 | -48.3% | -81.4% | €38.1m | €9.10 | PS3.1x | E33.8% | n/a | ||
ABNX | €1.22 | -2.3% | 1.3% | €41.5m | €11.50 | PS8.7x | E-23.4% | n/a | ||
ALVAL | €1.34 | -4.6% | -68.1% | €20.8m | €4.15 | PS40x | E19.4% | n/a | ||
IPH | €1.93 | 12.6% | -15.6% | €163.6m | €6.14 | PS4.8x | E42.4% | n/a | ||
ALGEN | €3.39 | 3.0% | -14.4% | €31.6m | n/a | PE24.9x | n/a | n/a |
Page 1 of 1